Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Katkin Keith Create: Alert

All | News | Filings
Date FiledTypeDescription
05/30/2023 4 Katkin Keith (Director) has filed a Form 4 on Emergent BioSolutions Inc.
Txns: Granted 33,847 shares @ $0
05/02/2023 4 Katkin Keith (Director) has filed a Form 4 on Eledon Pharmaceuticals, Inc.
Txns: Granted 752,185 options to buy @ $2.3, valued at $1.7M
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/07/2022 4 Katkin Keith (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc
Txns: Sold 20,782 shares @ $25.9009, valued at $538.3k
Sold 9,117 shares @ $25.9009, valued at $236.1k
Exercised 9,117 options to buy @ $8.93, valued at $81.4k
Exercised 20,782 options to buy @ $7.88, valued at $163.8k
10/04/2022 4 Katkin Keith (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc
Txns: Sold 2,914 shares @ $25.0707, valued at $73.1k
Sold 647 shares @ $25.0707, valued at $16.2k
Sold 167 shares @ $25, valued at $4.2k
Sold 13 shares @ $25, valued at $325
Sold 137 shares @ $25, valued at $3.4k
Sold 223 shares @ $25, valued at $5.6k
Exercised 647 options to buy @ $8.93, valued at $5.8k
Exercised 2,914 options to buy @ $7.88, valued at $23k
Exercised 13 options to buy @ $8.93, valued at $116.1
Exercised 167 options to buy @ $7.88, valued at $1.3k
Exercised 223 options to buy @ $8.93, valued at $2k
04/05/2022 4 Katkin Keith (Director) has filed a Form 4 on Emergent BioSolutions Inc.
Txns: Granted 8,595 shares @ $0
04/05/2022 3 Katkin Keith (Director) has filed a Form 3 on Emergent BioSolutions Inc.
02/03/2022 4 Katkin Keith (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc
Txns: Granted 16,000 shares @ $0
02/02/2022 4 Katkin Keith (Director) has filed a Form 4 on Eledon Pharmaceuticals, Inc.
Txns: Granted 20,000 options to buy @ $3.97, valued at $79.4k
05/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/15/2020 4 Katkin Keith (Director) has filed a Form 4 on Novus Therapeutics, Inc.
Txns: Granted 5,907 options to buy @ $500, valued at $3M
05/15/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/21/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/14/2020 4 Katkin Keith (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc
Txns: Granted 24,000 options to buy @ $9.47, valued at $227.3k
01/09/2020 4 Katkin Keith (PEO;CEO/Urovant Sciences, Inc.) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Granted 199,680 shares @ $0
12/11/2019 4 Katkin Keith (PEO;CEO/Urovant Sciences, Inc.) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Sold 120,000 shares @ $12.78, valued at $1.5M
Exercised 120,000 options to buy @ $3.86, valued at $463.2k
07/15/2019 4 Katkin Keith (Director) has filed a Form 4 on Novus Therapeutics, Inc.
Txns: Granted 20,000 options to buy @ $0.88, valued at $17.6k
06/12/2019 4 Katkin Keith (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc
Txns: Granted 24,000 options to buy @ $7.88, valued at $189.1k
05/24/2019 4 Katkin Keith (Director) has filed a Form 4 on RIGEL PHARMACEUTICALS INC
Txns: Granted 55,000 options to buy @ $2.02, valued at $111.1k
01/08/2019 4 Katkin Keith (PEO;CEO/Urovant Sciences, Inc.) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Granted 350,250 options to buy @ $6.88, valued at $2.4M
10/17/2018 4 Katkin Keith (PEO;CEO-Urovant Sciences,Inc.) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Granted 99,967 options to buy @ $13.65, valued at $1.4M
10/03/2018 4 Katkin Keith (PEO;CEO-Urovant Sciences,Inc.) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Granted 200,250 options to buy @ $0
09/28/2018 4 Katkin Keith (PEO;CEO-Urovant Sciences,Inc.) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Granted 39,815 options to buy @ $14, valued at $557.4k
09/26/2018 3 Form 3 - Initial statement of beneficial ownership of securities:
06/14/2018 4 Katkin Keith (Director) has filed a Form 4 on Novus Therapeutics, Inc.
Txns: Granted 9,100 options to buy @ $6.18, valued at $56.2k
05/25/2018 4 Katkin Keith (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc
Txns: Granted 14,000 options to buy @ $8.93, valued at $125k
05/18/2018 4 Katkin Keith (Director) has filed a Form 4 on RIGEL PHARMACEUTICALS INC
Txns: Granted 40,000 options to buy @ $3.98, valued at $159.2k
02/12/2018 4 Katkin Keith (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc
Txns: Granted 10,000 options to buy @ $9.63, valued at $96.3k
07/05/2017 4 Katkin Keith (Director) has filed a Form 4 on Novus Therapeutics, Inc.
Txns: Granted 36,000 options to buy @ $5.85, valued at $210.6k
05/12/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
05/11/2017 3 Katkin Keith (Director) has filed a Form 3 on Novus Therapeutics, Inc.
03/31/2017 4 Katkin Keith (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy